U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182864) titled 'MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis' on Sept. 12.

Brief Summary: This is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.

Study Start Date: Jan. 06, 2022

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis (AD)

Intervention: DRUG: MH004 0.1% Ointment

MH004 0.1% ointment applied topically to the affected area as a thin film.

DRUG: MH004 0.3% Ointment

MH004 0.3% ointment applied topically to the affected area as a thin film.

DRUG: MH004 1.0% Ointment

MH004 1.0% ointment applied topically to the ...